Founded Year
2005Stage
Series E - II | AliveTotal Raised
$90.65MLast Raised
$1.4M | 2 yrs agoAbout Adastra Pharmaceuticals
Adastra Pharmaceuticals is a private, clinical-stage biopharmaceutical company committed to providing responsible solutions to advance patient care in oncology. Its vision is to identify, develop, and deliver to patients important new therapies for diseases with significant unmet needs. This commitment is epitomized by its lead clinical candidate, zotiraciclib, which is initially being developed for the treatment of high-grade gliomas (HGG) and diffuse intrinsic pontine glioma (DIPG), two forms of brain cancer characterized by Myc overexpression. Adastra possesses a rich history of institutional and academic collaboration, including ongoing clinical research programs with the National Cancer Institute (NCI) and the European Organisation for Research and Treatment of Cancer (EORTC).
Adastra Pharmaceuticals Headquarter Location
202 Carnegie Center Suite 104
Princeton, New Jersey, 08540,
United States
760-208-6900
Latest Adastra Pharmaceuticals News
Oct 6, 2021
Cothera to Advance Clinical Development of Oral Kinase Inhibitor with Unique Myc Depletion I want to thank all the physicians and dedicated healthcare providers who have put forward relentless effort on behalf of their patients as the Adastra team transitions zotiraciclib into Cothera.” — Scott Megaffin, Chief Executive Officer, Adastra PRINCETON, NEW JERSEY, USA, October … Continue reading "Cothera Bioscience Acquires Zotiraciclib from Adastra Pharmaceuticals"
Expert Collections containing Adastra Pharmaceuticals
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Adastra Pharmaceuticals is included in 2 Expert Collections, including Cancer.
Cancer
4,784 items
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Biopharmaceuticals
5,882 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Adastra Pharmaceuticals Patents
Adastra Pharmaceuticals has filed 4 patents.
The 3 most popular patent topics include:
- Experimental cancer drugs
- Transcription factors
- Acute myeloid leukemia
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/12/2020 | 11/16/2021 | Transcription factors, Brain tumor, Oncology, Radiation therapy, Experimental cancer drugs | Grant | |
Application Date | 8/12/2020 | |||
|---|---|---|---|---|
Grant Date | 11/16/2021 | |||
Title | ||||
Related Topics | Transcription factors, Brain tumor, Oncology, Radiation therapy, Experimental cancer drugs | |||
Status | Grant |
